1. Differentiation of Solid Pseudopapillary Tumor and Non-Functional Neuroendocrine Tumors of the Pancreas Based on CT Delayed Imaging: A Propensity Score Analysis
- Author
-
Jianping Lu, Yun Bian, Jing Li, Jieyu Yu, Chengwei Shao, Li Wang, Yinghao Meng, Hui Jiang, Xiaochen Feng, Fang Liu, Hao Zhang, and Xu Fang
- Subjects
medicine.medical_specialty ,Non functional ,Neuroendocrine tumors ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Multidetector Computed Tomography ,Multidetector computed tomography ,medicine ,Humans ,Delayed imaging ,Radiology, Nuclear Medicine and imaging ,Propensity Score ,Pancreas ,Retrospective Studies ,business.industry ,Area under the curve ,medicine.disease ,Pancreatic Neoplasms ,Solid pseudopapillary tumor ,Neuroendocrine Tumors ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Propensity score matching ,Radiology ,business - Abstract
Purpose To evaluate the diagnostic performance of the delayed-phase difference between tumor and pancreas for differentiating solid pseudopapillary tumors (SPTs) from non-functional neuroendocrine tumors (NF-NETs) of the pancreas. Methods This retrospective review included 148 consecutive patients with SPT and 98 consecutive patients with NF-NET confirmed by pathology. Patients with SPT and NF-NET were matched via propensity score matching (PSM). All patients underwent multidetector computed tomography (MDCT). For each patient, the delayed-phase difference between the tumor and pancreas was measured, and the performance of this variable was assessed based on its discriminative ability and clinical utility. Results After PSM, 27 patients with SPT and 27 patients with NF-NET were included in the matched analysis. There were no statistically significant differences in clinical and CT characteristics between the resulting two groups (p > 0.05). The delayed-phase difference values between the tumor and pancreas were significantly lower in patients with SPT (median: -0.45; range: -2.05 to 0.73) than in patients with NF-NET (median: 0.71; range: -1.39 to 2.38). The delayed-phase difference between tumor and pancreas had a high diagnostic accuracy (area under the curve=0.88). The best cutoff point based on maximizing the sum of the sensitivity and specificity was -0.23 (sensitivity = 88.89%; specificity = 88.89%; accuracy = 0.89). Conclusions The delayed-phase difference between tumor and pancreas can accurately and noninvasively differentiate SPT from NF-NET.
- Published
- 2022